泰国丙型肝炎简化检测治疗策略:碧差汶模型
泰国碧差汶府丙型肝炎负担较重,采用快速诊断试纸即时筛查后行定性核酸检测的检测治疗策略,该简化策略显示在全国层面实施的较强潜力,但全民健康覆盖的严格标准、治疗政策持续修订、公众认知较低及政府政策优先级滞后构成实施障碍。
要点
- 快速诊断试纸即时筛查后行定性核酸检测的检测治疗策略,可促进人群丙型肝炎筛查并缩短治疗时间。
- 该简化策略在丙型肝炎负担较重的泰国碧差汶府进行评价,显示在全国层面实施的较强潜力。
- 全民健康覆盖标准严格优先晚期患者、治疗政策持续修订、公众认知较低及政策优先级滞后阻碍消除进展。
核心结论
- 该简化的丙型肝炎检测治疗策略显示在泰国全国层面实施的较强潜力。
研究设计与样本
- 在泰国丙型肝炎负担较重的碧差汶府评价快速诊断试纸即时筛查后行定性核酸检测的检测治疗策略。
主要发现
- 快速诊断试纸即时筛查后行定性核酸检测的检测治疗策略可促进人群丙型肝炎筛查并缩短治疗时间。
临床怎么用
- 原文未据此给出推荐。
局限性
- 全民健康覆盖的严格标准优先晚期患者构成实施障碍。
- 丙型肝炎治疗与照护政策持续修订构成实施障碍。
- 公众对丙型肝炎感染的认知相对较低构成实施障碍。
- 政府政策优先级滞后构成实施障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The complexity of the hepatitis C virus (HCV) diagnostic workflow and stringent criteria for universal health coverage are significant barriers to achieving HCV elimination in Thailand. A test-to-treat strategy using a rapid diagnostic test (RDT) for screening at point of care, followed by a qualitative nucleic acid testing, is a promising strategy to facilitate population-wide screening for HCV infection and expedite time to treatment. This strategy was evaluated in Phetchabun province, Thailand, where the HCV burden is relatively high. This simplified HCV test-to-treat strategy showed strong potential to be implemented at a national level. Several obstacles to implementation included the stringent criteria for universal health coverage, which prioritizes patients with advanced disease, the continuous policy revision for HCV treatment and care, the relatively low public awareness of HCV infection, and the lagging of government policy prioritization. All of these contribute to the delayed progress in hepatitis elimination.
引用
- Wasitthankasem R, Wanlapakorn N, Pimsing N, et al. Simplified Test-to-Treat Strategy for Hepatitis C in Thailand: The Phetchabun Model. J Infect Dis. 2023. PMID: 37703343. doi:10.1093/infdis/jiac490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。